Related Experiment Videos
HLA-G gene activation in tumor cells involves cis-acting epigenetic changes
Gaël Mouillot1, Céline Marcou, Philippe Rousseau
1Commissariat í l'Energie Atomique, Service de Recherches en Hémato-Immunologie, Direction des Sciences du Vivant/Département de Recherche Medicale, Institut Universitaire d'Hématologie, Hôpital Saint-Louis, Paris, France.
International Journal of Cancer
|October 30, 2004
Summary
Human Leukocyte Antigen-G (HLA-G) gene expression in tumors is regulated by DNA methylation. Demethylation activates HLA-G, suggesting a target for epigenetic cancer therapies.
Area of Science:
- Immunogenetics
- Epigenetics
- Cancer Biology
Background:
- Human Leukocyte Antigen-G (HLA-G) is expressed beyond trophoblastic cells, notably in malignant tumors.
- HLA-G plays a role in tumor immune escape, with regulatory mechanisms distinct from classical HLA class I genes.
- Epigenetic processes, including DNA methylation, are implicated in HLA-G gene regulation.
Purpose of the Study:
- To investigate the influence of DNA demethylation on HLA-G gene activation.
- To analyze the 5' regulatory region of HLA-G in melanoma and choriocarcinoma cell lines.
- To elucidate the epigenetic mechanisms silencing or activating HLA-G expression.
Main Methods:
- Analysis of the 5' regulatory region of HLA-G in FON, M8, JEG-3, and JAR cell lines.
- Assessment of DNA methylation status (CpG site hypermethylation) within the 5' regulatory region.
- Correlation of gene expression with histone acetylation and locus control region activity.
Main Results:
- HLA-G is silenced by CpG site hypermethylation in its 5' regulatory region (450 bp upstream of the start codon).
- Demethylation of this region leads to the activation of HLA-G expression.
- These epigenetic changes correlate with histone acetylation and the locus control region at -1.2 kb.
Conclusions:
- Epigenetic silencing via DNA hypermethylation is a key mechanism for controlling HLA-G expression in cancer.
- Demethylating agents can activate HLA-G expression, offering a potential therapeutic strategy.
- The findings highlight the importance of cis-acting epigenetic modifications in regulating HLA-G and their relevance for epigenetic cancer therapies.